1. Clinical trial end points for high-grade glioma: the evolving landscape;DA Reardon;Neuro Oncol,2011
2. Exploring multi-targeting strategies for the treatment of gliomas;AM Omuro;Curr Opin Investig Drugs,2008
3. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation;VM Zohrabian;Anticancer Res,2009
4. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas;T Nickl-Jockschat;Int J Oncol,2007
5. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways;H Song;Neurosci Res,2006